Lupus & antiphospholipid syndrome
Key considerations for advancing chimeric antigen receptor (CAR) T-cell therapy for systemic lupus erythematosus (SLE): a multi-partner/disciplinary working group perspective
Methodological detailsmulti-partner/disciplinary working group, public-private partnership
- Multi-partner/disciplinary working group
- Public-private partnership
Recommendations
As issued by the authors
Need for well-defined severity/refractoriness-based eligibility criteria
Need for long-term monitoring infrastructure
Need for educational and logistical support for rheumatologists and patients
Original publication
Key considerations for advancing chimeric antigen receptor (CAR) T-cell therapy for systemic lupus erythematosus (SLE): a multi-partner/disciplinary working group perspective. RMD Open. Published 5 October 2025. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →